Prosel Biosciences is developing two expression platforms for production of enzymes and proteins from recombinant green algae. Prosel Biosciences has patented Algaexpress™, a microalgae-based protein expression platform providing a sustainable, low-cost source of abundant recombinant food-grade proteins.

Spartina Biotechnologies’ patent pending SIREN™ technology is a radical departure from traditional antiviral drugs and vaccines used to control Coronavirus. Spartina uses natural short interfering RNA (siRNA) to engage the suppressed activities of the RNAi pathway and to activate the antiviral interferon-mediated antiviral pathway.

Bright Path Labs manufactures small molecules for life science companies. This agile and patented advanced pharmaceutical technology is paving the way for rapid, low-cost, and scalable domestic Advanced Pharmaceutical Ingredients (API) production.

Acoustic Biosystems develops blood sample preparation systems for improving clinical diagnostics at hospitals.

Cornerstone Innovation has developed a device to be used by anesthesiologists at Ambulatory Surgical Clinics (ASC) to improve the labeling of syringes and efficiency of regulatory compliance, such as recording the expiration and lot number of drugs administered.